OKYO Pharma Ltd L (OKYO)

London
Currency in GBP
Disclaimer
1.400
0.000(0.00%)
Closed
Trading near 52-week Low
Day's Range
1.4001.975
52 wk Range
1.400552.500
Prev. Close
1.85
Open
1.85
Day's Range
1.5-1.975
52 wk Range
1.5-552.5
Volume
0
Average Volume (3m)
22,473
1-Year Change
-99.46%
Shares Outstanding
28,219,944
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

OKYO Pharma Ltd L Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

Employees
7

Income Statement